SU886743A3 - Способ получени солей щелочных металлов производных 2-пиридил- или 2-пиримидиламинобензойной кислоты - Google Patents

Способ получени солей щелочных металлов производных 2-пиридил- или 2-пиримидиламинобензойной кислоты Download PDF

Info

Publication number
SU886743A3
SU886743A3 SU792765447A SU2765447A SU886743A3 SU 886743 A3 SU886743 A3 SU 886743A3 SU 792765447 A SU792765447 A SU 792765447A SU 2765447 A SU2765447 A SU 2765447A SU 886743 A3 SU886743 A3 SU 886743A3
Authority
SU
USSR - Soviet Union
Prior art keywords
amino
tetrazol
benzene ring
hydrogen
pyridyl
Prior art date
Application number
SU792765447A
Other languages
English (en)
Inventor
Шромм Курт
Ментруп Антон
Рент Эрнст-Отто
Фюгнер Армин
Якоби Фолькер
Original Assignee
К.Х.Берингер Зон (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by К.Х.Берингер Зон (Фирма) filed Critical К.Х.Берингер Зон (Фирма)
Application granted granted Critical
Publication of SU886743A3 publication Critical patent/SU886743A3/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Medicinal Preparation (AREA)

Description

(54) СПОСОБ ПОЛУЧЕНИЯ СОЛЕЙ ЩЕЛОЧНЫХ МЕТАЛЛОВ ПРОИЗВОДНЫХ
2-ПИРИДШ1- ИЛИ а-пиримидилАминоБЕнзойной кислоты 38 подвергают вазимодействию со щелочью и целевой продукт выдел ют в виде со ли щелочного металла. Целевые продукты могут примен тьс дл  терапевтических целей, например, в качестве реагентов антиаллергического действи , дл  лечени  аллергических болезней, таких как астма сенна  лихорадка, конъюнктивит, крапивна  лихорадка, экземы, атонический дерйатйт. Новые соединени , кроме того, имеют бронхорасшир ющие и сосудорасшир ющее действи . Пример 1. Динатриева  соль 4-(2-пиридиламино -изофталевой кислоты . 5,24 г цатриевой соли ll-H-11-оксо-пиридо- 2 ,1-в хиназолин-2-карбоновой кислоты и 20 мл 1 н; едкого натра йагревают на вод ной бане в течение 1 ч. Из полученного прозрачного желтого раствора удал ют воду в вид азеотропа с хлороформом. Полученные кристаллы суспендируют в небольшом количестве простого эфира, фильт уют и сушат в вакууме при . Выход 4,86 г (72% от теоретического. Вычислено, %: С 46,15; Н 55; N 8,28; 10,65. Найдено, %: С 46,04; Н 3,34|: МБ, 15; 11,1&. УФ-сиектрГЛупаХ логе4,18 4,30 Пример 2. Ди атриева  соль 2- (2-пиридиламинс) -5- (. 1 Н-тетразол-5г-ил )-бензойной кислоты. 8 г П-Н-11-оксопиридо-f 2,1-BJ-2- (1Н-тетразол-5-ил -хиназолина и 60,6 мл I Н. едкого натра нагревают цо 70 С в течение 2 ч, отгон ют воду и кристаллы суспендируют в небольшом количестве простого эфира, фильтруют ц сушат при в вакууме. Выход г { 76% от теоретического}. Вычислено %: С 41,05; Н 3,68; N22,10. ;,HgW. X ЗН,,0 Ийдеко, %: С 41,98; Н 3,54; И 22,18. УФ-спектр:Ху ЯХ,нм 290 317 доге 4,24 4,27 Пример 3. Дикалиева  соль 4-(. 2-пирндиламино) -изофталевой кислоты . 5,56 г (о,02 мол  калиевой сол  11-Н-1 Ноксо-пиридо-р, I-B хиназолин-2-карбоновой кислоты нагревают в течение 1 ч с 20 мл едкого кали. Из соответств щего раствора азеотроцно удал ют воду. Остаток суспевдйруют в простом эфире, отсасывают и сущат при 60 С. Выход соединени  составл ет 85% УФ-спектр:А,„ат1НМ 288 328 лог g 4,18 4,30 Аналогично получают натриевую соль соединений, приведенных в таблице.
f
НН-
(JOOdH;
4,18
80 4,40
4-(2-Хинолиниламино)изофталева  кислота
Нз y xx-CJOOH .j j ss x CJOOH
чАкн-4 ,25 84
320
лева  кислота 4-( 5-Ацетамидо-.2- еН -пиридиАамино ) -изо-, -пмпыпыН минг 1 фталева  кислота
Йродолжение таблицы ( J-NK.,, HDOd,C.OOH, , иI TVtи .Ло 4.25 .-Л 4,30 . l MoHo-N-(ш-тетраf золгЗ-ил -карбоксамид 4-(2-пиридилWx JJHамино )-изофталевЬй ,кислоты
Hood,,,/г
VCOOH
jT
f -NH886743
8 Продолжение таблицы.
Hood
4,30 75
325
54,6
с ООН
4,18
78,4 4,30
сбон
2,24
290
65, Р:F- K b-iJH-f 11 к

Claims (1)

  1. Формула изобретени 
    Способ получени  солей щелочных металлов производных 2-пиридйл- или 2-пиримидиламинобензойной кислоты общей формулы I
    СРОК
    бензольное кольцо или группа -CO-R в 4 или 5 положении кольца;
    rpyjtina -СО-ДЧ тетразол-5-ил, циан в 4 или 5 положении бензольного Кольца шш, если R означает группу -COR, то R - водород, метил, метокси или конденсированное бензольное кольцо;
    ft - окси, амино, гидроксиамино, тетразол-5-ил-амино или метокси, отличающийс  тем, что соедииение общей формулы 11
    в которой
    А - группа гСН- или
    R - водород, метил, метокси, амино, ацетамино, конденсированное.
    988674 . ,0
    гдеЛ yfl и А имеют указанные значе-Источники информации,
    ни , подвергают взаимодействию со ще- . прин тые во внимание при экспертизе лочью и целевой продукт выдел ют в 1. Патент Великобритании № 1064259, виде соли щелочного металла.кл. С 071 31/24, опублик. 1967.
SU792765447A 1977-08-10 1979-05-21 Способ получени солей щелочных металлов производных 2-пиридил- или 2-пиримидиламинобензойной кислоты SU886743A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19772735919 DE2735919A1 (de) 1977-08-10 1977-08-10 Neue 2-pyridyl- und 2-pyrimidylaminobenzoesaeuren

Publications (1)

Publication Number Publication Date
SU886743A3 true SU886743A3 (ru) 1981-11-30

Family

ID=6016013

Family Applications (2)

Application Number Title Priority Date Filing Date
SU782646404A SU735168A3 (ru) 1977-08-10 1978-08-08 Способ получени циклической карбоновой кислоты или ее соли
SU792765447A SU886743A3 (ru) 1977-08-10 1979-05-21 Способ получени солей щелочных металлов производных 2-пиридил- или 2-пиримидиламинобензойной кислоты

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SU782646404A SU735168A3 (ru) 1977-08-10 1978-08-08 Способ получени циклической карбоновой кислоты или ее соли

Country Status (32)

Country Link
US (1) US4241068A (ru)
JP (1) JPS5430177A (ru)
AT (1) AT370415B (ru)
AU (1) AU520240B2 (ru)
BE (1) BE869640A (ru)
BG (1) BG30472A1 (ru)
CA (1) CA1111037A (ru)
CH (1) CH649289A5 (ru)
CS (1) CS202506B2 (ru)
DD (1) DD140351A5 (ru)
DE (1) DE2735919A1 (ru)
DK (1) DK148019C (ru)
ES (5) ES472143A1 (ru)
FI (1) FI71555C (ru)
FR (1) FR2400017A1 (ru)
GB (1) GB2002764B (ru)
GR (1) GR65024B (ru)
HU (1) HU179933B (ru)
IE (1) IE47228B1 (ru)
IT (1) IT1107960B (ru)
LU (1) LU80094A1 (ru)
MX (1) MX5672E (ru)
NL (1) NL7808319A (ru)
NO (1) NO152605C (ru)
NZ (1) NZ188101A (ru)
PH (1) PH19117A (ru)
PL (2) PL115778B1 (ru)
PT (1) PT68407A (ru)
SE (1) SE444170B (ru)
SU (2) SU735168A3 (ru)
YU (1) YU40832B (ru)
ZA (1) ZA784501B (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3100516A1 (de) * 1981-01-10 1982-08-12 C.H. Boehringer Sohn, 6507 Ingelheim Pyridylaminobenzoesaeuren, ihre herstellung und verwendung
FR2533567A1 (fr) * 1982-09-23 1984-03-30 Ki I Farmakologii 2-(orthocarboxyphenylamino)-6h-pyrimido (2,1-b)-quinazolone-6 et ses derives, leur procede de preparation et leur application therapeutique
US4610991A (en) * 1983-04-18 1986-09-09 Sterling Drug Inc. Antihypertensive pyridylaminobenzamide compounds
JPS60100559A (ja) * 1983-11-05 1985-06-04 Morishita Seiyaku Kk 2−アニリノ−1,6−ジヒドロ−6−オキソ−5−ピリミジンカルボン酸誘導体,その製法及び該化合物を含有する抗アレルギ−剤
US4584379A (en) * 1985-01-22 1986-04-22 Merrell Dow Pharmaceuticals Inc. Isoquinoline thromboxane synthetase inhibitors
ATE68789T1 (de) * 1985-10-16 1991-11-15 Merck Frosst Canada Inc 2-substituierte chinoline.
GB9615950D0 (en) * 1996-07-30 1996-09-11 Univ Warwick Variable reluctance machines
US6022884A (en) 1997-11-07 2000-02-08 Amgen Inc. Substituted pyridine compounds and methods of use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1064259A (en) * 1963-12-19 1967-04-05 Union Pharma Scient Appl New derivatives of 2-anilino-nicotinic acid and process for their preparation
GB1162287A (en) * 1967-11-07 1969-08-20 Union Pharma Scient Appl New Salts of 2-Anilino-Nicotinic Acids
GB1264798A (ru) * 1968-07-10 1972-02-23
ES416847A1 (es) * 1973-07-12 1976-03-01 Hermes Sa Lab Procedimiento para la obtencion de derivados del acido ni- cotinico.

Also Published As

Publication number Publication date
NO782707L (no) 1979-02-13
CH649289A5 (de) 1985-05-15
CA1111037A (en) 1981-10-20
PL115778B1 (en) 1981-04-30
ZA784501B (en) 1980-04-30
DK148019C (da) 1985-07-01
BE869640A (fr) 1979-02-09
DD140351A5 (de) 1980-02-27
ATA549278A (de) 1982-08-15
ES472143A1 (es) 1979-03-16
IE781618L (en) 1979-02-10
YU191678A (en) 1983-01-21
HU179933B (en) 1983-01-28
DK148019B (da) 1985-02-04
AT370415B (de) 1983-03-25
PL115889B1 (en) 1981-05-30
JPS5430177A (en) 1979-03-06
JPS6231704B2 (ru) 1987-07-09
FI71555C (fi) 1987-01-19
SE7808530L (sv) 1979-02-11
NO152605B (no) 1985-07-15
BG30472A1 (en) 1981-06-15
AU3877278A (en) 1980-02-14
FI782039A (fi) 1979-02-11
DE2735919A1 (de) 1979-02-22
GR65024B (en) 1980-06-16
LU80094A1 (de) 1979-09-07
PH19117A (en) 1986-01-06
FI71555B (fi) 1986-10-10
GB2002764A (en) 1979-02-28
ES475456A1 (es) 1979-05-01
NL7808319A (nl) 1979-02-13
AU520240B2 (en) 1982-01-21
NZ188101A (en) 1981-01-23
FR2400017B1 (ru) 1983-03-11
IT7850642A0 (it) 1978-08-08
GB2002764B (en) 1982-08-04
DE2735919C2 (ru) 1988-10-27
CS202506B2 (en) 1981-01-30
NO152605C (no) 1985-10-23
SE444170B (sv) 1986-03-24
PL208942A1 (ru) 1979-12-03
MX5672E (es) 1983-12-08
SU735168A3 (ru) 1980-05-15
US4241068A (en) 1980-12-23
ES475457A1 (es) 1979-11-16
DK351978A (da) 1979-02-11
ES480622A1 (es) 1980-01-01
PT68407A (de) 1978-09-01
IE47228B1 (en) 1984-01-25
FR2400017A1 (fr) 1979-03-09
IT1107960B (it) 1985-12-02
YU40832B (en) 1986-06-30
ES480623A1 (es) 1980-01-01

Similar Documents

Publication Publication Date Title
RU2061695C1 (ru) Способ получения арилпиперазинил-гетероциклических соединений или их фармацевтически приемлемой кислотно-аддитивной соли
NO164537B (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive r(+)- og s(-)-carbazolderivater, og r(-)- og s(+)-4(2,3-epoxypropoxy)-carbazol for anvendelse ved fremgangsmaaten.
SU886743A3 (ru) Способ получени солей щелочных металлов производных 2-пиридил- или 2-пиримидиламинобензойной кислоты
JP3094535B2 (ja) 置換ピリミジン誘導体
JPH0144717B2 (ru)
NZ206234A (en) 6,7-dihydro-8-(imidazol-1-yl)-5-methyl-1-oxo-1h,5h-benzo(1,j)quinolizine-2-carboxylic acid derivatives and pharmaceutical compositions
SU1340585A3 (ru) Способ получени производных тетразола
US3960856A (en) Process for the preparation of 4-hydroxy-3-(5-methyl-3-isoxazolylcarbamoyl)-2-methyl-2H-1,2-benzothiazine 1,1-dioxide
NO811014L (no) Fremgangsmaate og mellomprodukter for fremstiling av 3,3`-azo-bis-(6-hydroksy-benzosyre)
US3499902A (en) Organic hydrazone compound containing azo coupler moiety
US4439436A (en) 1,3-Dioxolo(4,5-G)quinoline compounds
FR2581994A1 (fr) Procede de preparation de derives bis-(triazinyl-amino)-stilbeniques
RU2007146394A (ru) Способы получения гетероциклических соединений
SU626094A1 (ru) 5-Замещенные производные 5н-дибенз(в, )-азепина, как промежуточные продукты синтеза соединений, обладающих психотропным действием, и способ их получени
US4060527A (en) Pyrido[2,3-c]-acridine-1-hydroxy-2-carboxylic acid derivatives
AU610629B2 (en) Improvements in or relating to leukotriene antagonists
CA1104560A (en) Pyrrole cephalosporin derivatives
CH616679A5 (en) Process for the preparation of N-(5-tetrazolyl)-1-oxo-1H-pyrimido[1,2-a]quinoline-2-carboxamides
US3244725A (en) 4, 5-diacyl-3-hydroxy-3-pyrrolin-2-ones
US5565575A (en) Method for the production of 5-cyclohexylmethylhydantoin derivatives
AU672370B2 (en) New derivatives of fluoro-quinoline carboxylic-3 acid and preparation thereof
JPS6026381B2 (ja) 4−ヒドロキシベンゾフエノン類の塩基性エ−テルおよびその製法
EP0269841B1 (fr) 1-Hydroxyalkylxanthines, leurs procédés de préparation et médicament les contenant
JPH06239856A (ja) 1,3−ベンゾオキサチオール−2−チオン誘導体
DK158673B (da) Analogifremgangsmaade til fremstilling af cephalosporinforbindelser.